Status:
COMPLETED
Carbon Dioxide Versus Iodine Contrast for Endovascular Revascularization of Aortoiliac Occlusive Disease
Lead Sponsor:
Zagazig University
Conditions:
Aortoiliac Occlusive Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
From July 2015 to July 2018, 64 patients with aortoiliac occlusive disease who were eligible for endovascular treatment and lacked contraindications to either iodine contrast or carbon dioxide (CO2) w...
Detailed Description
Sampling The sample size was calculated by the intuitional review board statistician using open epi based on the RCT done by Mendes et al. Power of study as set at 80% and confidence interval set at 9...
Eligibility Criteria
Inclusion
- Patients with aortoiliac arteries atherosclerotic disease (with arterial atherosclerotic disease classified as Trans-Atlantic Inter-Society Consensus (TASC) A, B and C, (classified by CT angiography)
- Patients with good distal runoff
- Patients suitable for either types of contrast ICM or CO2 (No history of allergy to contrast and normal kidney functions)
Exclusion
- Patients with TASC D aortoiliac lesions
- Patients requiring femoral endartectomy
- Patient s with significant multilevel distal disease
- Patients suffering from severe chronic obstructive lung disease, chronic kidney failure, heart failure, or pregnancy.
- Patients younger than 18 years
Key Trial Info
Start Date :
July 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 15 2020
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT04458714
Start Date
July 1 2015
End Date
January 15 2020
Last Update
July 7 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.